RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CTSO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Tuesday for Cytosorbents Corporation stock after gaining 0.496%
(Updated on Apr 30, 2024)

Sell candidate since Apr 11, 2024 Loss -10.48% PDF

The Cytosorbents Corporation stock price gained 0.496% on the last trading day (Tuesday, 30th Apr 2024), rising from $0.81 to $0.81. During the last trading day the stock fluctuated 5.77% from a day low at $0.790 to a day high of $0.84. The price has risen in 6 of the last 10 days and is up by 1.54% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 92 thousand more shares were traded than the day before. In total, 137 thousand shares were bought and sold for approximately $110.87 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -17.75% during the next 3 months and, with a 90% probability hold a price between $0.625 and $0.784 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CTSO Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 2.53%. Further rise is indicated until a new top pivot has been found. Cytosorbents Corporation has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cytosorbents Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.82 and $0.89. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cytosorbents Corporation stock

Cytosorbents Corporation finds support from accumulated volume at $0.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0456 between high and low, or 5.77%. For the last week, the stock has had daily average volatility of 6.34%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTSO) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Cytosorbents Corporation to open at $0.81, and during the day (based on 14 day Average True Range), to move between $0.747 and $0.87, which gives a possible trading interval of +/-$0.0634 (+/-7.82%) up or down from last closing price. If Cytosorbents Corporation takes out the full calculated possible swing range there will be an estimated 15.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.81 (0.12%) than the resistance at $0.88 (8.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cytosorbents Corporation stock A Buy?

Cytosorbents Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.434 Sell Candidate Unchanged

Predicted Opening Price for Cytosorbents Corporation of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$0.81 ( 0.222%) $0.81

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CTSO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.86 5.85 %
R2 0.84 3.70 %
R1 0.83 2.37 %
Current price: 0.81
Support S1 0.794 -1.93 %
S2 0.784 -3.26 %
S3 0.766 -5.41 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.01 24.69 %
R2 0.96 17.90 %
R1 0.88 8.64 %
Current price 0.81
Support S1 0.81 -0.123%
S2 0.80 -1.11%
S3 0.798 -1.52%

FAQ

What is the symbol for Cytosorbents Corporation Stock and on which exchange is it traded?
The symbol for Cytosorbents Corporation is CTSO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cytosorbents Corporation Stock?
Cytosorbents Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cytosorbents Corporation Stock?
Cytosorbents Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cytosorbents Corporation Stock.

What's the current price of Cytosorbents Corporation Stock?
As of the end of day on the Apr 30, 2024, the price of an Cytosorbents Corporation (CTSO) share was $0.81.

What is the 52-week high and low for Cytosorbents Corporation Stock?
The 52-week high for Cytosorbents Corporation Stock is $4.29 and the 52-week low is $0.782.

What is the market capitalization of Cytosorbents Corporation Stock?
As of the Apr 30, 2024, the market capitalization of Cytosorbents Corporation is 43.761M.

When is the next earnings date for Cytosorbents Corporation?
The upcoming earnings date for Cytosorbents Corporation is May 09, 2024.
Click to get the best stock tips daily for free!

About Cytosorbents Corporation

Cytosorbents Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complication... CTSO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT